Kala’s Third Phase III Trial Should Line Up Approval In Dry Eye

 
• By Joseph Haas
Concept of eyesight, closeup of one eye with a target centred
Kala is targeting approval of Eysuvis by year's end in dry eye disease

More from New Products

More from Scrip